Here are four notes:
1. EndoChoice Holdings has a 12-month low of $6.23 and a 12-month high of $19.69.
2. The company has a 50-day moving average of $8.17 and a 200-day moving average of $12.29.
3. The firm’s market cap is $163.65 million.
4. On average, EndoChoice Holdings has a rating of “buy” and a target price of $23.33.
More articles on GI/endoscopy:
GI physician leader to know: Dr. David Alpers of Washington University at St. Louis
Frozen vs. fresh fecal matter for FMT — Does it make a difference? 4 insights
Midwest Gastroenterology adds Dr. Richard Lozoff — 3 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
